Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
118.69
-0.78 (-0.65%)
At close: Oct 9, 2026, 4:00 PM EDT
117.08
-1.61 (-1.35%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Haemonetics Market Cap
Haemonetics has a market cap or net worth of $5.4 billion as of October 9, 2026. It is the 3,450th most valuable company in the world and the 1,102nd biggest in the United States. Its market cap has increased by 119.86% in one year.
Market Cap
5.40B
Enterprise Value
6.35B
1-Year Change
119.86%
Global Rank
Country Rank
#1,102 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Haemonetics's market cap has increased from $605.00M to $5.40B, an increase of 792.57%. That is a compound annual growth rate of 8.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 5.40B | 43.93% |
| Dec 31, 2025 | 3.75B | -4.33% |
| Dec 31, 2024 | 3.92B | -9.62% |
| Dec 29, 2023 | 4.34B | 9.01% |
| Dec 30, 2022 | 3.98B | 46.84% |
| Dec 31, 2021 | 2.71B | -55.05% |
| Dec 31, 2020 | 6.03B | 3.54% |
| Dec 31, 2019 | 5.82B | 12.62% |
| Dec 31, 2018 | 5.17B | 68.56% |
| Dec 29, 2017 | 3.07B | 47.73% |
| Dec 30, 2016 | 2.08B | 26.98% |
| Dec 31, 2015 | 1.64B | -14.87% |
| Dec 31, 2014 | 1.92B | -11.51% |
| Dec 31, 2013 | 2.17B | 3.06% |
| Dec 31, 2012 | 2.11B | 37.73% |
| Dec 30, 2011 | 1.53B | -2.18% |
| Dec 31, 2010 | 1.56B | 10.69% |
| Dec 31, 2009 | 1.41B | -1.15% |
| Dec 31, 2008 | 1.43B | -10.77% |
| Dec 31, 2007 | 1.60B | 32.14% |
| Dec 29, 2006 | 1.21B | -6.31% |
| Dec 30, 2005 | 1.29B | 40.58% |
| Dec 31, 2004 | 920.10M | 59.08% |
| Dec 31, 2003 | 578.40M | 10.51% |
| Dec 31, 2002 | 523.40M | -41.55% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 10x Genomics | 10.71B |
| Globus Medical | 10.06B |
| Bio-Rad Laboratories | 9.79B |
| Bio-Rad Laboratories | 9.66B |
| Glaukos | 9.63B |
| Insulet | 9.34B |
| Bruker | 8.98B |
| Integer Holdings | 4.30B |